Stuart Henderson

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when Passage BIO, Inc. publishes a filing, an earnings call transcript or a press release.

Get PASG alerts

About Stuart Henderson

Stuart Henderson is recorded as Head of Investor Relations at Passage BIO, Inc. (PASG). Passage BIO, Inc. reported in an 8-K filed August 1, 2024 that Stuart Henderson was appointed Chief Business Officer, effective August 1, 2024. Stuart Henderson has spoken on 8 earnings calls across 1 company, most recently for Passage BIO, Inc. on March 6, 2023. Passage BIO, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Passage BIO, Inc. includes Peter Smith, Ph.D. (CEO), William Chou (CEO and Board Member), William Chou, M.D. (CEO and Board Member) and 7 others.

“On August 1, 2024, the Company announced the appointments of Susan Browne, Ph.D. as Chief Scientific Officer of the Company and Stuart Henderson as Chief Business Officer of the Company, each effective as of August 1, 2024.”

Passage BIO, Inc. Form 8-K, filed August 1, 2024 · Read the filing

Stuart Henderson on recent calls

“This morning we issued a press release that outlines the topics we plan to discuss today. This release is available on the Passage Bio website under the Press Releases and Statements section of Investors and News.”

Head of Investor Relations, Passage BIO, Inc. Q4 FY2022 Earnings Call · March 6, 2023

“This morning we issued a press release that outlines the topics we plan to discuss today. This release is available on the Passage Bio website under the Press Releases and Statements section of Investors and News.”

Head of Investor Relations, Passage BIO, Inc. Q3 FY2022 Earnings Call · November 10, 2022

“This morning we issued a press release that outlines the topics we plan to discuss today. This release is available on the Passage Bio website under the Press Releases and Statements section of Investors and News.”

Head of Investor Relations, Passage BIO, Inc. Q2 FY2022 Earnings Call · August 4, 2022

“This morning, we issued a press release that outlines the topics we plan to discuss today. This release is available on the Passage Bio website under the Press Releases and Statements section of Investors and News.”

Head of Investor Relations, Passage BIO, Inc. Q1 FY2022 Earnings Call · May 16, 2022

“This morning, we issued a press release that outlines the topics we plan to discuss today. This release is available on the Passage Bio website under the Press Releases and Statements section of Investors and News.”

Head of Investor Relations, Passage BIO, Inc. Q4 FY2021 Earnings Call · January 10, 2022